ADHERIUM LIMITED — Board/Management Information 2018

Sep 2, 2018

==> picture [211 x 51] intentionally omitted <==

Adherium Change of Auditor

San Mateo, CA – September 3, 2018: Adherium (ASX: ADR), (the Company or Adherium) advises that the Company has received approval from the Australian Securities and Investments Commission (ASIC) to change its auditors. Accordingly, the Company has now accepted the resignation of PricewaterhouseCoopers in New Zealand (“PwC NZ”) and the consent of PricewaterhouseCoopers in Australia (“PwC AU”) to its appointment as Adherium’s auditor.

The decision to change auditors was largely procedural with the Company, and both PwC NZ and PwC AU agreeing that Australian based ASX listed company audit expertise would be of benefit to Adherium.

In accordance with section 327C of the Corporations Act 2001, a resolution will be placed at the 2018 Annual General Meeting to ratify the appointment of PricewaterhouseCoopers in Australia as the Company’s auditor.

Rob Turnbull Company Secretary

About Adherium

Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices, with over 130,000 sold globally. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of connected medical devices for respiratory medications. The devices and accompanying technology address sub-optimal medication use and strive to improve health outcomes in chronic disease. Adherium is headquartered in the USA, and operates globally from bases in the USA, Europe and Australasia. Learn more at www.adherium.com